Report Overview

The global Crohns disease treatment market size stood at around USD 5 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

The Global Crohns Disease Market is expected to witness significant growth due to rising awareness about inflammatory bowel and Crohns diseases. Crohns diseases trigger due to bacterial, environmental and immune factors. Higher preference for symptomatic therapeutic, better treatment of inflammatory bowel diseases, arrival of enhanced drugs and healthier investments in R&D programs are the major factors contributing to the growth of the Crohns Disease market. Lack of early diagnosis techniques and High cost of treatment are the major factor restricting the growth of market.



Market Drivers

The global Crohns disease market is driven by increasing incidence of bowel disorders such as Crohns disease, leading to drug innovations for treatment. Crohns disease is more prevalent in developed and industrialized countries, particularly in individuals who smoke, and also with changing food habits, such as preference of fast food over vegetables and fruits. Therefore, rising patient population due to lifestyle changes and other factors also contributes to the expansion of the market. Furthermore, rising demand for biologics for treatment of bowel disorders such as Crohns disease, increasing awareness about Crohns disease, and the available treatments are estimated to propel the global market. Additionally, drug manufacturers are vigorously focusing on innovative products having more efficiency. Therefore, increased preference and utilization for anti-inflammatory drugs and biologics coupled with the rising acceptance of biosimilars is anticipated to play a significant role in boosting the Crohns disease market during the forecast period.